Which Healthcare ETF Is the Better Buy: State Street’s Pharma XPH or Simplify’s Mission-Driven PINK?
State Street's XPH and Simplify's PINK offer two distinct approaches to healthcare investing. XPH provides lower-cost, passive pharmaceutical exposure with stronger recent returns (30.5% vs 18.3%), while PINK offers active, broader healthcare management with higher dividend yield (0.8% vs 0.4%) and lower volatility. PINK uniquely donates its management fees to breast cancer research. XPH suits cost-conscious pharma investors, while PINK appeals to those seeking active management and philanthropic impact.